Patterns of anti-cancer therapy use in the last 14 days of life in a community cancer institute.
Caitlyn McNaughton(Lancaster General Hospital), Shanthi Sivendran(Lancaster General Hospital), Kristina Newport(Pennsylvania State University), Jason H. Moore(Cedars-Sinai Medical Center), Riley Wong(University of Pennsylvania), Selah Lynch(University of Pennsylvania), Sarah Svetec(American Institutes for Research), Randall A. Oyer(Lancaster General Hospital), Rachel Holliday(Lancaster General Hospital)
Cited by 0
Related Papers
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521
Breast cancer risk–associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression
|Nature Genetics|2012|379
Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement
|Journal of Clinical Oncology|2022|238
GAMETES: a fast, direct algorithm for generating pure, strict, epistatic models with random architectures
|BioData Mining|2012|229
Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease
|Journal of the American Heart Association|2017|136